Basics |
Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is primarily engaged in research and development activities.
|
IPO Date: |
September 11, 2017 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$240.56M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.18 | 2.50%
|
Avg Daily Range (30 D): |
$0.17 | 2.05%
|
Avg Daily Range (90 D): |
$0.18 | 2.58%
|
Institutional Daily Volume |
Avg Daily Volume: |
.09M |
Avg Daily Volume (30 D): |
.05M |
Avg Daily Volume (90 D): |
.07M |
Trade Size |
Avg Trade Size (Sh.): |
126 |
Avg Trade Size (Sh.) (30 D): |
80 |
Avg Trade Size (Sh.) (90 D): |
96 |
Institutional Trades |
Total Inst.Trades: |
35 |
Avg Inst. Trade: |
$2.88M |
Avg Inst. Trade (30 D): |
$.69M |
Avg Inst. Trade (90 D): |
$.94M |
Avg Inst. Trade Volume: |
.36M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$6.2M |
Avg Closing Trade (30 D): |
$.69M |
Avg Closing Trade (90 D): |
$.69M |
Avg Closing Volume: |
755.98K |
|
|
Financials |
|
TTM |
Q1 2025 |
Q4 2024 |
Basic EPS
|
$-.53
|
$-.04
|
$-.08
|
Diluted EPS
|
$-.53
|
$-.04
|
$-.08
|
Revenue
|
$ 30.91M
|
$ 8.75M
|
$ 7.93M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -14.44M
|
$ -1.17M
|
$ -1.99M
|
Operating Income / Loss
|
$ -11.98M
|
$ -.81M
|
$ -.93M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ M
|
$ M
|
$ M
|
PE Ratio
|
|
|
|
Splits |
Sep 05, 2014:
1:3
|
Aug 30, 2011:
1:18
|
Aug 02, 2005:
1:5
|
|
|
|